2005        !"#$%&'()*+,)-.%/012345
1987  1989      !"# $%&'()*+',- ./!

 "#$ '%&')*() 0*  1989 '1!234+,'-, 5.67!
8'./ ,- .9:01/ 234;5<06=4$7

>9? @A+.89B

CDEF6GH!IJKL 0*  :MN',- ., ;O0P<Q (PAF) .<' @A+'

GC/MS+' GC/MS

RS =T & U.V,- .WXDYZ.<';[\]Y E .>?4^.
O  =._>`a* bc!L @*+'1!23.dA`

.eBC$ bc!L\YfC DE gh U.Fi4`a*j[kY\YfCl:'DEmnShGoHpmngh Uq`,- ./ "#$ ` rI')*+.j[kY\YfC s'P  HPLC tL 0* Pl@ 0* `aj7uv3E!JKj w8F w]1`ax

LM- `Ny':0P g A j[kYtL S LC/MSIJKL'zx 234._O'{`oj ]CD HPLC

w8F.9:01.15|'>hgP}'^S LC/MS IJKL'zxQ1RS .~TjYZ234;JGHY

U.<') 0* U.V 1996 $JC8JV S. Kent W.`8cP 1997 $ B. Chait

W.` MS 'z*\YfC^   U g U.N 'hAX MS !J.
8DK]CJ'Y`Z+g'[) \ m$'

YZP\YfC _O)*+. YZ

P8DK!L.[) 0* U. ]^   zx<\YfC :'')*+'75_P.`$ LC/MS .a T."#$) b gh* c'/;T. 4.
d7'e(rI'f8DK!L^IJKL.a;zxgf YZP8DK!L^).0* @gh*hij.+' E'ag MS+'MS 'mRS.nE)kl.[)`a* q. MSIR_r8DF£!7 SA{`ou

U.=T RS gv¦ h{'©$hO

&gh*

z{gªx U.=T=·'h¡q.¢-r

 k KH!a¤n*T.¥s0*'t
 whAxA §¨>>l y'Y'{)*¥sg|*  2003 .>o­`0®mn~ 51 ¯°`jf³! ´µo*¶h'['SA U.

MS $@$n*!\#$op`a*«}¬mngh|@±² gU.j3

 nw`a*­x`o ¸V.

¹ ghoºo » $n '¤m¼ h+$n

1678(9:1)

T. Nakagawa, Y. Oda, A. Shibukawa, and H. Tanaka, Separation and determination of cefpiramide
in human plasma by electrokinetic chromatography with a micellar solution and an open
tubular-fused silica capillary, Chem. Pharm. Bull., 36, 1622῍1625 (1988).
2) Y. Oda, N. Asakawa, T. Kajima, Y. Yoshida, and T. Sato, Column-switching high-performanceliquid chromatography for on-line simultaneous determination and resolution of enantiomers ofverapamil and its metabolites in plasma, Pharm. Res., 8, 997῍1001 (1991).
3) Y. Oda, N. Mano, and N. Asakawa, Quantitation of platelet-activating factor in biological samples
using liquid chromatography/mass spectrometry with column-switching technique, Anal. Bioῌ 68 ῌchem., 231, 141῍150 (1995).
K. Matsui, Y. Oda, H. Ohe, S. Tanaka, and N. Asakawa, Direct determination of E2020 enantiomers
in plasma by liquid chromatography-mass spectrometry and column-switching techniques, J.
Chromatogr., 694, 209῍218 (1995).
5) Y. Oda, N. Mano, and N. Asakawa, Simultaneous quantitation of thromboxane B2, prostaglandin E2
and leukotriene B4 in whole blood by liquid chromatography/mass spectrometry, J. Mass Spectrom., 30, 1671῍1678 (1995).
6) N. Mano, Y. Oda, and N. Asakawa, Plasma direct injection high-performance liquid chromatographic method for simultaneously determination E3810 enantiomers and their metabolites by using
ﬂavoprotein-conjugated column, J. Pharm. Sci., 85, 903῍907 (1996).
7) N. Mano, Y. Oda, K. Yamada, N. Asakawa, and K. Katayama, Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization
tandem mass spectrometry, Anal. Biochem., 244, 291῍300 (1997).
8) M. R. Carrasco, M. C. Fitzgerald, Y. Oda, and S. B. H. Kent, Direct monitoring of organic reactions
on polymeric supports, Tetrahedron Lett., 38, 6331῍6334 (1997).
9) T. Takenawa, Y. Oda, Y. Ishihama, and M. Iwakura, Cyanocysteine-mediated molecular dissectionof dihydrofolate reductase: Occurrence of intra- and inter-molecular reactions forming a peptidebond, J. Biochem., 123, 1137῍1144 (1998).
10) Y. Ishihama, O. Ito, Y. Oda, T. Takenawa, and M. Iwakura, A novel method for peptide blocksynthesis using unprotected peptides, Tetrahedron Lett., 40, 3415῍3418 (1999).
11) Y. Oda, K. Huang, F. R. Cross, D. Cowburn, and B. T. Chait, Accurate quantitation of protein
expression and site-speciﬁc phosphorylation, Proc. Natl. Acad. Sci. USA, 96, 6591῍6596 (1999).
12) K. Matsui, Y. Oda, H. Nakata, and T. Yoshimura, Simultaneous determination of donepezil (aricept)
enantiomers in human plasma by liquid chromatography῍electrospray tandem mass spectrometry, J. Chromatogr. B, 729, 147ῌ155 (1999).
13) H. Katayama, Y. Ishihama, Y. Oda, and N. Asakawa, Electrophoretic mobility-assisted identiﬁcation of proteins by nanoelectrospray capillary electrophoresis/mass spectrometry under methanolic conditions, Rapid Commun. Mass Spectrom., 14, 1167῍1178 (2000).
14) Y. Oda, T. Nagasu, and B. T. Chait, Enrichment analysis of phosphorylated proteins as a tool forprobing the phosphoproteome, Nature Biotechnol., 19, 379῍382 (2001).
15) H. Katayama, T. Nagasu, and Y. Oda, Improvement of in-gel digestion protocol for peptide massﬁngerprinting by matrix assisted laser desorption/ionization῍time of ﬂight mass spectrometry,Rapid Commun. Mass Spectrom., 15, 1416῍1421 (2001).
16) K. Satoh, M. Takeuchi, Y. Oda, M. Deguchi-Tawarada, Y. Sakamoto, K. Matsubara, T. Nagasu, andY. Takai, Identiﬁcation of activity-regulated proteins in the postsynaptic density fraction, Genes
Cells, 7, 187῍197 (2002).
17) T. Matsu-ura, T. Nakadai, Y. Oda, T. Nagasu, K. Mikoshiba, and T. Tamura, Seizure-mediatedaccumulation of the beta subunit of Ca2῍/calmodulin-dependent protein kinase II in nuclei ofmouse brain cells, Neurosci. Lett., 322, 149῍152 (2002).
18) Y. Ishihama, H. Katayama, N. Asakawa, and Y. Oda, Highly robust stainless steel tips as microelectrospray emitters, Rapid Commun. Mass Spectrom., 16, 913῍918 (2002).
19) Y. Oda, T. Owa, T. Sato, B. Boucher, S. Daniels, H. Yamanaka, Y. Shinohara, A. Yokoi, J. Kuromitsu,and T. Nagasu, Quantitative chemical proteomics for identifying candidate drug targets, Anal.
Chem., 75, 2159῍2165 (2003).
20) H. Katayama, K. Satoh, M. Takeuchi, M. Deguchi-Tawarada, Y. Oda, and T. Nagasu, Optimizationof in-gel digestion system in combination with thin gel separation and negative staining in 96-wellplate format, Rapid Commun. Mass Spectrom., 17, 1071῍1078 (2003).
21) K. Tomizawa, S. Sunada, Y. F. Lu, Y. Oda, M. Kinuta, T. Ohshima, T. Saito, F. Y. Wei, M. Matsushita,
S. T. Li, K. Tsutsui, S. Hisanaga, K. Mikoshiba, K. Takei, and H. Matsui, Cophosphorylation ofamphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synapticvesicles, J. Cell Biol., 163, 813῍824 (2003).
22) H. Y. Wu, K. Tomizawa, Y. Oda, F. Y. Wei, Y. F. Lu, M. Matsushita, S. T. Li, A. Moriwaki, and H.
Matsui, Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration,
J. Biol. Chem., 279, 4929῍4940 (2004).
23) H. Katayama, T. Tabata, Y. Ishihama, T. Sato, Y. Oda, and T. Nagasu, E$cient in-gel digestion
procedure using 5-cyclohexyl-1-pentyl-b-9-maltoside as an additive for gel-based membrane proteomics, Rapid Commun. Mass Spectrom., 18, 2388῍2394 (2004).
24) Y. Ishihama, T. Sato, T. Tabata, N. Miyamoto, K. Sagane, T. Nagasu, and Y. Oda, Quantitative
mouse brain proteomics using culture-derived isotope tags as internal standards, Nature Biotechnol., 23, 617῍621 (2005).
25) M. Kokubu, Y. Ishihama, T. Sato, T. Nagasu, and Y. Oda, Speciﬁcity of immobilized metal
a$nity-based IMAC/C18 tip enrichment of phosphopeptides for protein phosphorylation analysis,Anal. Chem., 77, 5144῍5154 (2005).
῏῎ 25 ῐῌ4)

ῌ 69 ῌ